Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy

Bone Marrow Transplant. 2023 Apr;58(4):443-445. doi: 10.1038/s41409-022-01905-1. Epub 2022 Dec 22.

¹ Myeloma Center, Division of Hematology Oncology, University of Arkansas for Medical Sciences, Little Rock, AR, USA. salhadidi@uams.edu.
² Bone Marrow Transplant Service, Division of Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
³ Myeloma Center, Division of Hematology Oncology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
⁴ Division of Hematology/Oncology, Department of Medicine, Mayo Clinic, Rochester, AZ, USA.
⁵ Bone Marrow Transplant Service, Division of Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI, USA. memohan@mcw.edu.

No abstract available

Publication types